Cargando…
SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
BACKGROUND: The SUMO-activating enzyme SAE1 is indispensable for protein SUMOylation. A dysregulation of SAE1 expression involves in progression of several human cancers. However, its biological roles of SAE1 in glioma are unclear by now. METHODS: The differential proteome between human glioma tissu...
Autores principales: | Yang, Yanfang, Liang, Ziwei, Xia, Zijing, Wang, Xixi, Ma, Yanni, Sheng, Zenghua, Gu, Qingjia, Shen, Guobo, Zhou, Liangxue, Zhu, Hongxia, Xu, Ningzhi, Liang, Shufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659289/ https://www.ncbi.nlm.nih.gov/pubmed/31345225 http://dx.doi.org/10.1186/s12964-019-0392-9 |
Ejemplares similares
-
MS‐based strategies for identification of protein SUMOylation modification
por: Sheng, Zenghua, et al.
Publicado: (2019) -
Protein SUMOylation modification and its associations with disease
por: Yang, Yanfang, et al.
Publicado: (2017) -
Downregulation of ARHGDIA contributes to human glioma progression through activation of Rho GTPase signaling pathway
por: Lu, Weiliang, et al.
Publicado: (2016) -
SUMOylation modification-mediated cell death
por: Sheng, Zenghua, et al.
Publicado: (2021) -
Multifunctional Pharmaceutical Effects of the Antibiotic Daptomycin
por: Ye, Yang, et al.
Publicado: (2019)